Search results
Results from the WOW.Com Content Network
Ketamine has been tested as a rapid-acting antidepressant [13] for treatment-resistant depression in bipolar disorder, and major depressive disorder. [14] Spravato, a nasal spray form of esketamine, was approved by the FDA in 2019 for use in treatment-resistant depression when combined with an oral antidepressant. [15] [16]
Ketamine-assisted psychotherapy (KAP) is the use of prescribed doses of ketamine as an adjunct to psychotherapy sessions. KAP shows significant potential in treating mental disorders such as treatment-resistant depression (TRD), anxiety, obsessive–compulsive disorders (OCD), post-traumatic stress disorders (PTSD), and other conditions. [1]
[14] [17] The United States Food and Drug Administration has granted "breakthrough therapy" status, which expedites the potential approval of promising drug therapies, [note 2] to psychedelic therapies using psilocybin (for treatment-resistant depression and major depressive disorder) [8] and MDMA (for post-traumatic stress disorder).
At lower, sub-anesthetic doses, it is a promising agent for treatment of pain and treatment-resistant depression. [22] As with many antidepressants, the results of a single administration wane with time. [23] Ketamine is used as a recreational drug for its hallucinogenic and dissociative effects. [24]
[266] [267] A review article published in 2007 found psychostimulants may be effective in treatment-resistant depression with concomitant antidepressant therapy, but a more certain conclusion could not be drawn due to substantial deficiencies in the studies available for consideration, and the somewhat contradictory nature of their results.
They are best known as effective antidepressants, especially for treatment-resistant depression and atypical depression. [1] They are also used to treat panic disorder, social anxiety disorder, Parkinson's disease, and several other disorders. Reversible inhibitors of monoamine oxidase A (RIMAs) are a subclass of MAOIs that selectively and ...
This article needs to be updated. The reason given is: Many outdated sources and information (older than five years). Please help update this article to reflect recent events or newly available information. (July 2024) Medical condition Major depressive disorder Other names Clinical depression, major depression, unipolar depression, unipolar disorder, recurrent depression Specialty Psychiatry ...
Polymethyl methacrylate is the clear break-resistant sheeting sold as acrylic glass (or simply acrylic sheet) or under the trade name Plexiglas, Perspex, etc. Polyacrylates are used in cosmetic products as rheology modifiers and film formers, and these are typically polymers of acrylic acid fluids.